Literature DB >> 18824825

Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood.

Russell A Barkley1.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a common, chronic, and costly disorder, with an impact that can span from preschool into adulthood. There are safe and effective therapies that can manage and help prevent many of the associated negative outcomes of ADHD, but treatment rates are far from optimal and considerable obstacles exist in achieving satisfactory treatment adherence. Individuals with untreated ADHD, their families, and other caregivers must be made aware of the impact that this disorder may have on them at every stage of life and, correspondingly, the improved outcomes that can be achieved with the successful management of ADHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824825     DOI: 10.3810/pgm.2008.09.1907

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  14 in total

1.  Persisting Psychosocial Impairments in Adults Being Treated with Medication for Attention Deficit/Hyperactivity Disorder.

Authors:  Thomas E Brown; Emuella Flood; Phillip Sarocco; Norman Atkins; Alexandra Khachatryan
Journal:  Psychopharmacol Bull       Date:  2017-09-15

Review 2.  Attention-deficit/hyperactivity disorder and adverse health outcomes.

Authors:  Joel T Nigg
Journal:  Clin Psychol Rev       Date:  2012-12-07

Review 3.  Emerging support for a role of exercise in attention-deficit/hyperactivity disorder intervention planning.

Authors:  Olga G Berwid; Jeffrey M Halperin
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

4.  Chiropractic care for paediatric and adolescent Attention-Deficit/Hyperactivity Disorder: A systematic review.

Authors:  Fay Karpouzis; Rod Bonello; Henry Pollard
Journal:  Chiropr Osteopat       Date:  2010-06-02

Review 5.  The association of ADHD symptoms to self-harm behaviours: a systematic PRISMA review.

Authors:  Clare S Allely
Journal:  BMC Psychiatry       Date:  2014-05-07       Impact factor: 3.630

6.  Association between societal costs and treatment response in children and adolescents with ADHD and their parents. A cross-sectional study in the Netherlands.

Authors:  Annemarie van der Kolk; Clazien Am Bouwmans; Saskia J Schawo; Jan K Buitelaar; Michel van Agthoven; Leona Hakkaart-van Roijen
Journal:  Springerplus       Date:  2015-05-15

7.  Adult attention-deficit hyperactivity disorder: Why should we pay attention?

Authors:  Renata Schoeman; Ruth Albertyn; Manie de Klerk
Journal:  S Afr J Psychiatr       Date:  2017-08-31       Impact factor: 1.550

Review 8.  Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review.

Authors:  Tamás Treuer; Luis Méndez; William Montgomery; Shenghu Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-03       Impact factor: 2.570

9.  Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial.

Authors:  Renée Meppelink; Esther I de Bruin; Susan M Bögels
Journal:  BMC Psychiatry       Date:  2016-07-26       Impact factor: 3.630

10.  Involvement of family environmental, behavioral, and social functional factors in children with attention-deficit/hyperactivity disorder.

Authors:  Yanhong Huang; Haiyun Xu; William Au; Chongtao Xu; Kusheng Wu
Journal:  Psychol Res Behav Manag       Date:  2018-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.